Literature DB >> 7829245

Prostate cancer risk in U.S. blacks and whites with a family history of cancer.

R B Hayes1, J M Liff, L M Pottern, R S Greenberg, J B Schoenberg, A G Schwartz, G M Swanson, D T Silverman, L M Brown, R N Hoover.   

Abstract

Prostate cancer occurs more frequently in U.S. blacks than whites. A population-based case-control study which investigated the association with family history of cancer was carried out among 981 men (479 black, 502 white) with pathologically confirmed prostate cancer, diagnosed between August 1, 1986, and April 30, 1989, and 1,315 controls (594 black, 721 white). Study subjects, aged 40-79, resided in Atlanta, Detroit, and 10 counties in New Jersey, geographic areas covered by population-based cancer registries. Prostate cancer risk was significantly elevated among those who reported a history of prostate cancer in first-degree relatives (O.R. = 3.2; 95% C.I.: 2.0-5.0), with blacks and whites having similarly elevated risks. These risks were unchanged by statistical adjustment for job-related socio-economic status, education, income, and marital status. Overall, the ORs associated with history of prostate cancer in fathers and brothers were 2.5 (95% C.I.: 1.5-4.2) and 5.3 (95% C.I.: 2.3-12.5), respectively. Risks associated with a family history of prostate cancer were consistently elevated among younger and older subjects. Only small non-significant excesses of prostate cancer risk were associated with a family history of breast, colorectal, or other cancers. While familial occurrence is a key risk factor for prostate cancer and likely to be genetically based, the similar familial risks among blacks and whites suggest that the ethnic disparity in incidence is influenced by environmental factors.

Entities:  

Mesh:

Year:  1995        PMID: 7829245     DOI: 10.1002/ijc.2910600315

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  35 in total

1.  Segregation analyses of 1,476 population-based Australian families affected by prostate cancer.

Authors:  J Cui; M P Staples; J L Hopper; D R English; M R McCredie; G G Giles
Journal:  Am J Hum Genet       Date:  2001-04-11       Impact factor: 11.025

2.  Evidence for a rare prostate cancer-susceptibility locus at chromosome 1p36.

Authors:  M Gibbs; J L Stanford; R A McIndoe; G P Jarvik; S Kolb; E L Goode; L Chakrabarti; E F Schuster; V A Buckley; E L Miller; S Brandzel; S Li; L Hood; E A Ostrander
Journal:  Am J Hum Genet       Date:  1999-03       Impact factor: 11.025

Review 3.  A review of African American-white differences in risk factors for cancer: prostate cancer.

Authors:  Irina Mordukhovich; Paul L Reiter; Danielle M Backes; Leila Family; Lauren E McCullough; Katie M O'Brien; Hilda Razzaghi; Andrew F Olshan
Journal:  Cancer Causes Control       Date:  2010-12-24       Impact factor: 2.506

Review 4.  Prostate cancer: 3. Individual risk factors.

Authors:  R P Gallagher; N Fleshner
Journal:  CMAJ       Date:  1998-10-06       Impact factor: 8.262

5.  Cancer clinical outcomes for minority ethnic groups.

Authors:  P Selby
Journal:  Br J Cancer Suppl       Date:  1996-09

6.  A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.

Authors:  Thomas J Hoffmann; Stephen K Van Den Eeden; Lori C Sakoda; Eric Jorgenson; Laurel A Habel; Rebecca E Graff; Michael N Passarelli; Clinton L Cario; Nima C Emami; Chun R Chao; Nirupa R Ghai; Jun Shan; Dilrini K Ranatunga; Charles P Quesenberry; David Aaronson; Joseph Presti; Zhaoming Wang; Sonja I Berndt; Stephen J Chanock; Shannon K McDonnell; Amy J French; Daniel J Schaid; Stephen N Thibodeau; Qiyuan Li; Matthew L Freedman; Kathryn L Penney; Lorelei A Mucci; Christopher A Haiman; Brian E Henderson; Daniela Seminara; Mark N Kvale; Pui-Yan Kwok; Catherine Schaefer; Neil Risch; John S Witte
Journal:  Cancer Discov       Date:  2015-06-01       Impact factor: 39.397

Review 7.  Prostate cancer.

Authors:  D Mazhar; J Waxman
Journal:  Postgrad Med J       Date:  2002-10       Impact factor: 2.401

8.  Prostate cancer risk in men with prostate and breast cancer family history: results from the REDUCE study (R1).

Authors:  J-A Thomas; L Gerber; D M Moreira; R J Hamilton; L L Bañez; R Castro-Santamaria; G L Andriole; W B Isaacs; J Xu; S J Freedland
Journal:  J Intern Med       Date:  2012-01-16       Impact factor: 8.989

9.  Single and multivariate associations of MSR1, ELAC2, and RNASEL with prostate cancer in an ethnic diverse cohort of men.

Authors:  Joke Beuten; Jonathan A L Gelfond; Jennifer L Franke; Stacey Shook; Teresa L Johnson-Pais; Ian M Thompson; Robin J Leach
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-01-19       Impact factor: 4.254

10.  Familial clustering of breast and prostate cancer and risk of postmenopausal breast cancer in the Women's Health Initiative Study.

Authors:  Jennifer L Beebe-Dimmer; Cecilia Yee; Michele L Cote; Nancie Petrucelli; Nynikka Palmer; Cathryn Bock; Dorothy Lane; Ilir Agalliu; Marcia L Stefanick; Michael S Simon
Journal:  Cancer       Date:  2015-03-09       Impact factor: 6.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.